Intramuscular Interferon Beta-1a in combination with azathioprine and low-dose steroids for relapsing-remitting multiple sclerosis: design and preliminary results of a two-year double-blind, randomized, placebo-controlled study

Abstract

Interferon beta 1a, azathioprine, low-dose steroids, multiple sclerosis